Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

rodgergraham

Roger Graham appointed president of Mylan Specialty

June 25, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Mylan, graham, specialty

Mylan has hired previous J&J vice president Roger Graham to be president of its specialty business. Graham will report to …
Appointment
dinesh_c

BMS appoints Harman International chief executive

June 24, 2013 Manufacturing and Production, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has appointed Harman’s chief executive Dinesh Paliwal to its Board of directors.Paliwal will serve as a member of …
Appointment

Viagra patent expiry opens up market

June 24, 2013 Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra

Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …
News

Lundbeck cuts more jobs in Europe

June 24, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Lexapro, Lundbeck, cuts

Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …
News
Haslam image

David Haslam: a new chairman for a new NICE

June 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Hasmam, NHS, NICE

When NICE was first set up in 1999, technology appraisals of new medicines were its sole focus, but over the …
Feature

J&J opens office at Stevenage Bioscience Catalyst

June 21, 2013 Manufacturing and Production, Research and Development J&J, JJ, bioscience, catalyst

Johnson & Johnson Innovation has establishment a partnering office at Stevenage Bioscience Catalyst to support emerging entrepreneurs and biotech firms …
News
john_garibotto

John Garibotto joins Cellnovo’s Board

June 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cellnovo, Garibotto

UK-based medical device firm Cellnovo has appointed John Garibotto as a non-executive director. Garibotto is a 20-year veteran of the …
Appointment
Sanofi image

Sanofi makes Curie cancer deal

June 20, 2013 Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie

Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
News
screen_shot_2013-06-20_at_09

InHealthcare appoints NHS director

June 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing InHealthcare

Digital healthcare firm InHealthcare has appointed NHS director Simon Jones as its new commercial director.Jones has held positions in Acute Hospitals, Mental Health and …
Appointment
united_drug

United Drug hires Abbott VP

June 19, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Abbott, United Drug

Healthcare services firm United Drug has appointed Brendan McAtamney as chief operating officer with effect from September. McAtamney will be …
Appointment
Lilly image

Lilly pays Transition $7 million

June 19, 2013 Research and Development, Sales and Marketing Transition, lilly

Eli Lilly is to take up its option to develop and commercialise a type 2 diabetes candidate, paying Canadian firm …
News
Cambridge image

AstraZeneca chooses Cambridge for global HQ

June 19, 2013 Research and Development, Sales and Marketing AstraZeneca, Cambridge, MedImmune

AstraZeneca has chosen the Cambridge Biomedical Campus on the outskirts of the city as a new research and corporate hub. …
News
Avastin image

Avastin gets GBM approval

June 18, 2013 Research and Development, Sales and Marketing GBM, Roche, avastin

Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …
News
Medimmune image

MedImmune signs diabetes deal

June 18, 2013 Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes

AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …
News
J&J image

J&J to pay up to $1 billion in Aragon deal

June 18, 2013 Research and Development, Sales and Marketing Aragon, J&J, JJ, Zytiga

Johnson & Johnson could pay as much as $1 billion to buy prostate cancer specialist Aragon Pharmaceuticals. The acquisition includes …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026